{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-078774","form_type":"8-K","ticker":"LXEO","cik":"0001907108","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2024-06-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.176325+00:00","generated_at":"2026-06-01T00:50:08.991566+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lexeo Therapeutics stockholders elect Class I director, ratify KPMG as auditor","bullets":["Mette Kirstine Agger elected Class I director with 14,499,254 FOR, 7,450,057 WITHHELD, 1,249,160 broker non-votes.","Ratification of KPMG LLP as auditor for FY2024 passed: 23,194,982 FOR, 3,088 AGAINST, 401 ABSTAIN.","Annual meeting held virtually on June 25, 2024; no other proposals were voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-078774","json":"https://secwatch.observer/filing/0000950170-24-078774.json","markdown":"https://secwatch.observer/filing/0000950170-24-078774.md","text":"https://secwatch.observer/filing/0000950170-24-078774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/0000950170-24-078774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000095017024078774/lxeo-20240628.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:50:08.991566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}